4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1/MRP modulator.

Autor: Khatir, Zahra Zakeri, Di Sotto, Antonella, Percaccio, Ester, Tuylu Kucukkilinc, Tuba, Ercan, Ayse, Chippindale, Ann M., Valipour, Mehdi, Irannejad, Hamid
Zdroj: Archiv der Pharmazie; Jun2024, Vol. 357 Issue 6, p1-18, 18p
Databáze: Complementary Index
Externí odkaz: